BNP Paribas Financial Markets’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $171K | Sell |
5,448
-7,362
| -57% | -$311K | ﹤0.01% | 4304 |
|
|
2026
Q1 | $709K | Sell |
12,810
-152
| -1% | -$7.24K | ﹤0.01% | 3383 |
|
|
2025
Q4 | $484K | Sell |
12,962
-29,831
| -70% | -$1.21M | ﹤0.01% | 3587 |
|
|
2025
Q3 | $1.73M | Buy |
42,793
+22,535
| +111% | +$744K | ﹤0.01% | 2712 |
|
|
2025
Q2 | $517K | Buy |
20,258
+5,452
| +37% | +$119K | ﹤0.01% | 3306 |
|
|
2025
Q1 | $316K | Sell |
14,806
-782
| -5% | -$17.5K | ﹤0.01% | 3446 |
|
|
2024
Q4 | $327K | Sell |
15,588
-8,748
| -36% | -$202K | ﹤0.01% | 3573 |
|
|
2024
Q3 | $548K | Buy |
24,336
+729
| +3% | +$14.1K | ﹤0.01% | 2821 |
|
|
2024
Q2 | $396K | Sell |
23,607
-59,572
| -72% | -$957K | ﹤0.01% | 2785 |
|
|
2024
Q1 | $1.08M | Buy |
83,179
+9,892
| +13% | +$119K | ﹤0.01% | 2449 |
|
|
2023
Q4 | $849K | Buy |
73,287
+54,506
| +290% | +$615K | ﹤0.01% | 2484 |
|
|
2023
Q3 | $240K | Buy |
18,781
+935
| +5% | +$13.3K | ﹤0.01% | 3025 |
|
|
2023
Q2 | $244K | Buy |
17,846
+3,813
| +27% | +$54.6K | ﹤0.01% | 2932 |
|
|
2023
Q1 | $215K | Buy |
14,033
+5,084
| +57% | +$77.7K | ﹤0.01% | 3116 |
|
|
2022
Q4 | $120K | Sell |
8,949
-1,744
| -16% | -$23.4K | ﹤0.01% | 3189 |
|
|
2022
Q3 | $142K | Buy |
10,693
+508
| +5% | +$8.77K | ﹤0.01% | 3633 |
|
|
2022
Q2 | $195K | Buy |
10,185
+193
| +2% | +$3.65K | ﹤0.01% | 3101 |
|
|
2022
Q1 | $199K | Buy |
9,992
+255
| +3% | +$5.15K | ﹤0.01% | 3134 |
|
|
2021
Q4 | $199K | Sell |
9,737
-10,156
| -51% | -$217K | ﹤0.01% | 3400 |
|
|
2021
Q3 | $428K | Buy |
19,893
+12,679
| +176% | +$305K | ﹤0.01% | 2805 |
|
|
2021
Q2 | $208K | Buy |
7,214
+2,515
| +54% | +$68K | ﹤0.01% | 2856 |
|
|
2021
Q1 | $115K | Sell |
4,699
-425
| -8% | -$9.6K | ﹤0.01% | 3295 |
|
|
2020
Q4 | $99.5K | Sell |
5,124
-174
| -3% | -$3.2K | ﹤0.01% | 3209 |
|
|
2020
Q3 | $92.2K | Buy |
5,298
+3,596
| +211% | +$76.7K | ﹤0.01% | 3165 |
|
|
2020
Q2 | $44.7K | Sell |
1,702
-6,878
| -80% | -$171K | ﹤0.01% | 3083 |
|
|
2020
Q1 | $207K | Buy |
8,580
+3,564
| +71% | +$87.1K | ﹤0.01% | 2839 |
|
|
2019
Q4 | $125K | Buy |
5,016
+1,333
| +36% | +$30.9K | ﹤0.01% | 3183 |
|
|
2019
Q3 | $78.6K | Buy |
3,683
+678
| +23% | +$18.6K | ﹤0.01% | 3246 |
|
|
2019
Q2 | $95.5K | Sell |
3,005
-1,708
| -36% | -$53.6K | ﹤0.01% | 3062 |
|
|
2019
Q1 | $156K | Buy |
4,713
+4,254
| +927% | +$132K | ﹤0.01% | 2842 |
|
|
2018
Q4 | $14.8K | Sell |
459
-665
| -59% | -$25.1K | ﹤0.01% | 3208 |
|
|
2018
Q3 | $48.2K | Sell |
1,124
-837
| -43% | -$39.5K | ﹤0.01% | 3060 |
|
|
2018
Q2 | $90.3K | Sell |
1,961
-4,478
| -70% | -$198K | ﹤0.01% | 2841 |
|
|
2018
Q1 | $256K | Sell |
6,439
-1,824
| -22% | -$67.6K | ﹤0.01% | 2654 |
|
|
2017
Q4 | $277K | Sell |
8,263
-1,813
| -18% | -$64.4K | ﹤0.01% | 2798 |
|
|
2017
Q3 | $373K | Buy |
10,076
+4,143
| +70% | +$156K | ﹤0.01% | 2129 |
|
|
2017
Q2 | $220K | Buy |
5,933
+2,123
| +56% | +$69.3K | ﹤0.01% | 2391 |
|
|
2017
Q1 | $107K | Sell |
3,810
-294
| -7% | -$8.29K | ﹤0.01% | 2468 |
|
|
2016
Q4 | $120K | Buy |
4,104
+865
| +27% | +$23.6K | ﹤0.01% | 2449 |
|
|
2016
Q3 | $88K | Sell |
3,239
-2,911
| -47% | -$65.8K | ﹤0.01% | 2160 |
|
|
2016
Q2 | $115K | Buy |
6,150
+3,114
| +103% | +$64.9K | ﹤0.01% | 2080 |
|
|
2016
Q1 | $82.1K | Sell |
3,036
-1,742
| -36% | -$49.9K | ﹤0.01% | 1856 |
|
|
2015
Q4 | $144K | Buy |
4,778
+1,049
| +28% | +$33.7K | ﹤0.01% | 2122 |
|
|
2015
Q3 | $118K | Buy |
3,729
+2,137
| +134% | +$78K | ﹤0.01% | 2283 |
|
|
2015
Q2 | $62K | Buy |
1,592
+1,246
| +360% | +$43K | ﹤0.01% | 2357 |
|
|
2015
Q1 | $12.3K | Buy |
+346
| New | +$11.1K | ﹤0.01% | 2627 |
|
|
2014
Q4 | – | Sell |
-890
| Closed | -$19.9K | – | 2844 |
|
|
2014
Q3 | $19.9K | Buy |
+890
| New | +$17.8K | ﹤0.01% | 3168 |
|
Other funds holding PAHC
CM
BNP Paribas Financial Markets's PAHC Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Phibro Animal Health (PAHC) stake by 57% in Q2 2026, selling an estimated $311K and leaving 5,448 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #4304.
BNP Paribas Financial Markets first reported a position in PAHC in Q3 2014 and has held it in 47 quarters since. The position peaked at $1.73M in Q3 2025. 195 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- BNP Paribas Financial Markets held 5,448 shares of Phibro Animal Health worth $171K as of Q2 2026.
- BNP Paribas Financial Markets sold 7,362 Phibro Animal Health shares in Q2 2026, an estimated $311K.
- Phibro Animal Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4304 holding.
- BNP Paribas Financial Markets first reported a position in Phibro Animal Health in Q3 2014 and has held it in 47 quarters since.
- BNP Paribas Financial Markets's Phibro Animal Health position peaked at $1.73M in Q3 2025.
- 195 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.